Plain-English translation of NCT06667141 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is a Phase 1 trial testing a new medication called for people with advanced solid tumors. Researchers want to find the right dose of the medication that works best and causes the fewest side effects. The trial will also look at how the medication moves through your body and whether it helps shrink tumors.
This trial exists because cancer treatments that work for some patients don't work for others, and doctors need new options for people whose tumors have stopped responding to standard therapies. This medication is a completely new approach that hasn't been tested in humans before, so researchers need to first understand how safe it is and what dose works best.
You likely qualify if…
You likely don't qualify if…
You would receive the medication as an injection or infusion on a repeating schedule (either every 3 weeks or every 4 weeks, depending on which group you're in). The trial has two phases: first, researchers will gradually increase your dose to find the safest level, then expand to more participants at that dose. You'll have regular clinic visits for blood tests, imaging scans to measure your tumor, and check-ins about any side effects you experience.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States